A comparison of atomoxetine administered as once versus twice daily dosing on the school and home functioning of children with attention-deficit/hyperactivity disorder.

Waxmonsky JG, Waschbusch DA, Akinnusi O, Pelham WE. A comparison of atomoxetine administered as once versus twice daily dosing on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Feb; 21(1):21-32.

View in: PubMed

subject areas

Adrenergic Uptake Inhibitors
Attention Deficit Disorder with Hyperactivity
Behavior Therapy
Child
Combined Modality Therapy
Drug Administration Schedule
Female
Humans
Male
Parents
Propylamines
Schools
Treatment Outcome

authors with profiles

William Pelham

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support